Literature DB >> 10674989

Retrovirus mediated gene transfer of the self antigen MBP into the bone marrow of mice alters resistance to experimental autoimmune encephalomyelitis.

T R Peters1, D M Bodine, K T McDonagh, A Lovett-Racke, H F McFarland, D E McFarlin, A W Nienhuis, M K Racke.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a prototypic model of organ specific autoimmunity. MHC class II restricted T-cells directed against myelin basic protein (MBP) have been shown to cause EAE in susceptible strains of mice. We have asked whether the introduction of a gene encoding an autoantigen (MBP) into the hematopoetic stem cells of mice would result in tolerance to that protein. We have introduced cDNA encoding the 21.5 kDa isoform of MBP into the hematopoetic stem cells of B10.PL (73NS), SJL, and B10 mice by retrovirus-mediated gene transfer. Our experiments show expression of proviral MBP in peripheral blood and thymus following transplantation of genetically modified stem cells. Such expression does not result in deletion of MBP-specific T cells or tolerance to MBP, nor does it alter susceptibility to MBP-induced EAE in susceptible strains B10.PL and SJL. However, retrovirus-mediated gene transfer resulted in resistant B10 mice developing mild EAE. This report demonstrates that autoreactive MBP-specific T cells can be selected in the presence of endogenous antigen or an MBP-encoding retrovirus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674989     DOI: 10.1016/s0165-5728(99)00181-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells.

Authors:  Ulrike Baranyi; Birgit Linhart; Nina Pilat; Martina Gattringer; Jessamyn Bagley; Ferdinand Muehlbacher; John Iacomini; Rudolf Valenta; Thomas Wekerle
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

2.  Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.

Authors:  Herena Eixarch; Carmen Espejo; Alba Gómez; María José Mansilla; Mireia Castillo; Alexander Mildner; Francisco Vidal; Ramón Gimeno; Marco Prinz; Xavier Montalban; Jordi Barquinero
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

3.  Engraftment of retrovirally transduced Bet v 1-GFP expressing bone marrow cells leads to allergen-specific tolerance.

Authors:  Martina Gattringer; Ulrike Baranyi; Nina Pilat; Karin Hock; Christoph Klaus; Elisabeth Buchberger; Haley Ramsey; John Iacomini; Rudolf Valenta; Thomas Wekerle
Journal:  Immunobiology       Date:  2013-03-30       Impact factor: 3.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.